Colchicine plus Dapsone in Colchicine‐Resistant FMF Patients

Five to ten percent of FMF patients have unfavorable response to the colchicine as a standard therapy. Biologic treatments have been shown to be highly effective, but there are often unavailable, because the price is unaffordably high. This study shows the striking effect of combined dapsone and col...

Descripción completa

Detalles Bibliográficos
Autores principales: Salehzadeh, Farhad, Enteshary, A., Moshkbar, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343160/
https://www.ncbi.nlm.nih.gov/pubmed/30729059
http://dx.doi.org/10.1155/2019/2716127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343160/
https://www.ncbi.nlm.nih.gov/pubmed/30729059
http://dx.doi.org/10.1155/2019/2716127

Ejemplares similares